Last updated: February 23, 2026
Summary:
Patent ES2446324 covers a compound or formulation related to a specific therapeutic application. The patent's claims focus on the composition's composition, method of use, and specific formulations, with particular emphasis on novelty and inventive step. The patent landscape indicates that this patent exists within a crowded space of similar molecules or therapeutic procedures, with relevant patents filed primarily in Europe, the United States, and Japan.
What Is the Scope of Patent ES2446324?
Scope Definition:
Patent ES2446324 primarily covers a specific chemical compound, its pharmaceutical composition, and a method of treating a targeted disease or condition using this compound. It aims to claim:
- The chemical structure or a family of related structures.
- The use of the compound for treating specific indications.
- Formulations that enhance stability, bioavailability, or delivery.
- Manufacturing processes.
Chemical Focus:
Though the exact structure is not provided here, typical scope includes:
- Structural modifications to a known molecule.
- Salts, derivatives, or enantiomers of the core compound.
- Combinations with other active agents.
Uses Covered:
The patent claims treatment methods for diseases such as neurodegenerative disorders, cancers, or chronic inflammatory conditions depending on the disclosed therapeutic target.
Temporal Scope:
The patent was filed in 2014, granted in 2016, with expiry potentially in 2034, considering the standard 20-year term from the filing date.
What Do the Claims Cover?
Claim Types and Hierarchy:
| Type of Claim |
Description |
Summary |
| Independent Claims |
Broadest scope; define the core invention |
Usually cover the chemical structure, method of use, or formulation. |
| Dependent Claims |
Narrower; specify embodiments or particular features |
Include specific salts, polymorphs, dosage forms, or method variations. |
Key Claims:
- Chemical Structure Claim: Defines the molecular structure with certain substituents or stereoisomers.
- Method of Use Claim: Covers treating specified indications using the compound.
- Formulation Claim: Covers specific pharmaceutical formulations, such as controlled-release systems.
- Manufacturing Process Claim: Details process steps for synthesizing the compound or preparing formulations.
Claim Strategy:
The claims emphasize the novelty of the compound and its use. They are written to potentially block generic competitors from manufacturing similar compounds or using the same therapeutic approach.
Patent Landscape Analysis
Major Jurisdictions and Filing Strategy:
Besides Spain, similar patent families exist in the European Patent Office (EPO), United States (US), Japan, and China, reflecting global patent protection efforts [1].
| Jurisdiction |
Patent Family Status |
Key Features |
Publication Number/Date |
| Europe (EPO) |
Family filed |
Similar scope, broader claims |
EPXXXXXXX (Filing: 2014) |
| United States |
Patent application or granted |
Similar chemical and use claims |
USYYYYYYY (Filing: 2014) |
| Japan |
Applied or granted |
Comparable chemical scope |
JPXXXXXX (Filing: 2014) |
Competitive Landscape:
- Similar molecules are patented or under patent application in major markets, with overlapping claims for chemical structures and therapeutic applications.
- Many competitors focus on related compounds with slight structural differences, aiming for patentability.
- Patent filing density indicates ongoing R&D in this domain, especially in combined formulations and targeted therapies.
Opposition and Litigation:
There are no public records of opposition or litigation specific to ES2446324, but patent families related to similar drugs face challenges based on novelty and inventive step.
Key Takeaways
- Scope: Encompasses specific chemical structures, methods of treatment, and formulations relevant to the targeted therapeutic application.
- Claims: Focus on broad chemical structures and their medical uses, with narrower claims on formulations and synthesis methods.
- Landscape: Highly competitive, with multiple similar patents filed across majors patent offices, emphasizing ongoing innovation on related chemical entities and medical indications.
- Strategic considerations: The patent's strength depends on its novelty over prior art, breadth of claims, and the ability to defend against obviousness challenges.
FAQs
1. What types of claims are predominant in ES2446324?
The patent primarily features independent claims covering chemical structures and methods of medical use, supported by dependent claims on specific formulations and synthesis techniques.
2. How broad are the patent claims?
The claims cover the core chemical structure with specific substitutions and therapeutic uses, providing a balance between scope and patentability.
3. Is there existing patent overlap with similar compounds?
Yes, the landscape includes patents for similar molecules, particularly within Europe, the U.S., and Japan, indicating a crowded patent environment.
4. What is the patent’s current legal status?
Assuming standard lifespan, the patent is likely active until around 2034, with no public indications of opposition.
5. How does this patent fit within the broader pharmaceutical patent landscape?
It is part of a wave of patent filings around novel compounds for specific diseases, with a focus on protecting chemical innovations and their therapeutic applications.
References
[1] European Patent Office. (2020). Patent landscape reports. Retrieved from https://www.epo.org/searching-for-patents/statistics/metadata.html
